Navigation Links
Bayer Employees Named Rising Stars by Healthcare Businesswomen's Association
Date:5/3/2012

MORRISTOWN, N.J. and TARRYTOWN, N.Y., May 3, 2012 /PRNewswire/ -- Bayer HealthCare is pleased to announce two employees have been named Rising Stars by The Healthcare Businesswomen's Association (HBA). They were honored at the annual HBA Woman of the Year luncheon in New York City on May 3.

Mary Puncochar, Area Sales Manager, U.S. Sales and Marketing, Bayer HealthCare Diabetes Care, and Laura Schwieterman, Senior Brand Manager, U.S. Marketing, Bayer HealthCare Consumer Care, were the recipients. The honor is bestowed upon professionals who contribute significantly to their organizations, exemplify leadership, are role models for others and exhibit dedication to the healthcare industry.

Mary was honored for creating several programs to aid sales representatives and managers in achieving their career goals, including a new mentorship program that has been adopted nationwide.  "Mary's abilities to develop leaders, manage and lead change and inspire others continue to strengthen the organization," said Michael E. Mathews, Region Head, North America Bayer Diabetes Care and Senior Vice President, Bayer HealthCare.

Laura was recognized for leading the Alka-Seltzer Plus® team to reach a decade-long sales goal and launching a new product in record time. "Laura exemplifies a Rising Star through her business results and leadership of initiatives that better the organization," said Timothy Hayes, Senior Vice President of Bayer HealthCare Consumer Care's North American Region and Head of Global Business Development.

Both women act as leaders and mentors within the Bayer HealthCare organization by championing the national Women's Leadership Initiative (WLI) program, designed to cultivate successful women leaders to strengthen business results.

About Bayer HealthCare
The Bayer Group is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Bayer HealthCare, a subgroup of Bayer AG with annual sales of EUR 17.2 billion (2011), is one of the world's leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Consumer Care, Medical Care and Pharmaceuticals divisions. Bayer HealthCare's aim is to discover, develop, manufacture and market products that will improve human and animal health worldwide. Bayer HealthCare has a global workforce of 55,700 employees (Dec 31, 2011) and is represented in more than 100 countries. Find more information at www.bayerhealthcare.com.

BAYER and the Bayer Cross are registered trademarks of Bayer. 

 

 


'/>"/>
SOURCE Bayer HealthCare
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. U.S. FDA Clears Bayer HealthCares CONTOUR® Next EZ Blood Glucose Monitoring System
2. Piramal Healthcare Limited Acquires Molecular Imaging Development Portfolio of Bayer Pharma
3. Bayer Expands Its Hemophilia Leadership Development Program
4. Phase III Data Show Bayers Investigational Compound Regorafenib (BAY 73-4506) Met Primary Endpoint Showing Statistically Significant Improvement in Overall Survival in Patients with Metastatic Colorectal Cancer Refractory to Standard Approved Thera
5. Phase 3 Data Show Bayers Investigational Compound Regorafenib (BAY 73-4506) Met Primary Endpoint Showing Statistically Significant Improvement in Overall Survival in Patients with Metastatic Colorectal Cancer Refractory to Standard Approved Therapi
6. Ventana Medical Systems, Inc. to Collaborate with Bayer on Companion Diagnostic Test for New Biological Cancer Therapy
7. Gastrointestinal Cancers Symposium of the American Society of Clinical Oncology (ASCO-GI): Phase III Data on Bayers Investigational Compound Regorafenib (BAY 73-4506) in Patients with Metastatic Colorectal Cancer to be Presented as Late Breaking Or
8. Intendis, Inc. Changes Name to Bayer HealthCare
9. Bayers Xarelto® (rivaroxaban) Becomes First Fixed Dose Once-Daily Anticoagulant Tablet Approved in the UK for Stroke Prevention in non-valvular Atrial Fibrillation; and the First Single Drug Regimen for Deep Vein Thrombosis
10. Bayers Drospirenone-containing Combination Oral Contraceptives: FDA Advisory Committees Affirm Positive Benefit-risk Profile and Recommend an Update of Labels to Reflect Information From Available Studies
11. Bayer HealthCare LLC Stops Trademark Infringement by Indian Pharmaceutical Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... April 19, 2017 Global Surgical Drainage Device ... tubes used to remove excess liquid and air. The ... urine, bile or lymph. Surgical drains are used in ... as orthopedics surgery, cardiovascular surgery, neurosurgery, plastic surgery etc. ... to prevent accumulation of fluid e.g. blood or pus. ...
(Date:4/19/2017)... 19, 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... company developing new treatments for cancer and other ... its previously announced underwritten public offering of 23,625,084 ... offering price of $2.00 per share, before deducting ... payable by Sorrento.  The net proceeds to Sorrento ...
(Date:4/19/2017)... , April 19, 2017  SARES•REGIS Group ... it is developing at Conejo Spectrum Business Park ... to Atara Biotherapeutics, Inc. , a biopharmaceutical ... and life-threatening diseases that have been underserved by ... T-cell therapies for cancer, autoimmune and infectious disease. ...
Breaking Medicine Technology:
(Date:4/25/2017)... Richmond, BC (PRWEB) , ... April 25, 2017 , ... ... patients from Richmond, BC, who live with dental fear and require sedation to receive ... anxiety at ease during various procedures, from hygienic cleanings to oral surgery, at ...
(Date:4/25/2017)... , ... April 25, 2017 , ... ... they rely on contracted partners to help with process innovation in drug formulation ... drug formulation experience along with state-of-the-art analytical equipment in support of their development ...
(Date:4/25/2017)... MN (PRWEB) , ... April 25, 2017 , ... Buyers ... and recreational users to dispensaries and head shops –can’t help but be heartened by ... for the tell-tale cannabis odor aptly described as “skunk smell.” At last they ...
(Date:4/25/2017)... ... 25, 2017 , ... Emergency Physician and Distinguished Professor of Emergency Medicine Bentley ... in Writing, set to publish in summer 2017. , Dr. Bobrow, MD, FACEP, ... Arizona College of Medicine. He also serves as Medical Director for the Bureau of ...
(Date:4/25/2017)... ... April 25, 2017 , ... Amendia, Inc., designer, developer, and ... partnership with and platinum sponsorship of Global Spine Outreach (“GSO”), a charitable organization ... of complex spine deformity cases, particularly in children. , GSO’s focus is to ...
Breaking Medicine News(10 mins):